• Info
  • Insider Ownership

Insider Trading & Ownership of Christopher Gibson

Location
Salt Lake City, UT
Summary
The estimated net worth of Christopher Gibson is at least $2,957,352 dollars as of 10 Apr 2026. Christopher Gibson is the Director of RECURSION PHARMACEUTICALS, INC. and owns shares of RECURSION PHARMACEUTICALS, INC. (RXRX) stock worth about $2.81M. Christopher Gibson is the Director of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. and owns shares of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) stock worth about $147K.
Signature
/s/ Brett Atkins, Attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Christopher Gibson and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Quick Takeaways

  • Christopher Gibson has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $2,957,352.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: RECURSION PHARMACEUTICALS, INC. ($2,810,323).
  • Past-year value change for that position: -$7,514,964.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Christopher Gibson

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RXRX RECURSION PHARMACEUTICALS, INC. Director $2,810,323 -$7,514,964 -73% 07 Apr 2026
PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Director $147,029 08 Apr 2026

Insider Transactions Reported by Christopher Gibson:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.